Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The SNOO Smart Sleeper has demonstrated in aggregated data an average increase of approximately one hour of infant sleep per night and significant reductions in fussing. Clinical surveys report improved quality of care and time savings for clinicians using the device in hospital settings. The SNOO received De Novo FDA authorization as a Class II medical device for its ability to keep infants safely on their backs during sleep—a key factor in reducing SIDS risk[1][5].
"Aggregated SNOO Sleep Log data (n=72,649) indicates that SNOO use is associated with increase of approximately one hour of sleep per night... nurses and other clinicians agreed that SNOO enhances the quality of infant care (99%), reduces fussing (98%), and gives staff extra time to focus on other tasks (97%)."[1][3]
No pharmaceutical clinical trials are conducted as this is a device/consumer health company.
Used by over 150 hospitals worldwide[6].
Endorsed by pediatricians and supported by published research abstracts/posters at major conferences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Happiest Baby.